marijuana stocks news

FutureWorld (FWDG) Unveils “Essence” Real Hemp CBD Oil Through its New Subsidiary, NutraCann Labs, Inc.

Concentrated Pharmaceutical Grade Hemp CBD Oil for Wholesale & Retail Sale 

ST. PETERSBURG, FL, Jan. 14, 2015 (GLOBE NEWSWIRE) — FutureWorld Corp. (FWDG), a leading provider of advanced technologies and solutions to the global cannabis industry, announces today the launch of EssenceTM CBD, a high concentration, all-natural, Cannabidiol-rich Hemp Oil through its subsidiary, NutraCann Labs, Inc.

Initial retail sales will be through 1ml cartridges, 10ml & 50ml bottles and starter kits with the sleek URVape vaporizer pen. Bulk rate kilograms will also be available at the wholesale level. The product is available immediately online at and . “We anticipate rolling out a full-line of products relating to CBD in the very near future. I am excited to be teaming up with our sister company URVape, Inc. to provide high quality, CBD rich, vapable hemp oil through “SafeVape” vaporizers online”, said CEO of NutraCann Labs, Inc., Don Ballou.

The Company has spent the last few months ensuring all source material was free of heavy metals or other toxins. The results of the company’s efforts have made available an absolutely pristine quality whole-food supplement that represents “the Essence” of the plant says Don Ballou. There are some hundreds of phytonutrients that exist in hemp plants and it is absolutely essential to capture the full spectrum of these valuable & beneficial molecules. Using Super Critical Extraction Technology (CO2) makes it possible to extract the essential phytonutrients without the use of excessive heat or other undesirable solvents.

NutraCann’s Real Pharmaceutical Grade CBD-rich hemp oil comes from the whole hemp plant and does not contain any synthetics nor is it an isolate.

FutureWorld is committed to being a leader in the space for product safety and quality control. With so many snake oils, imitations and down-right “zero-potency” CBD oil being sold on the market today at obscene prices, we have made it our cause to bring much needed legitimacy and integrity back to the market.

“Since our announcement on December 10, 2014, we have received numerous phone calls, emails, and other inquiries regarding the sale of our CBD products. While we have already begun to sell some to wholesale suppliers, we have also created our own brand to make sure that we can take advantage of the burgeoning retail market,” commented CEO Sam Talari. “We are determined to create a brand with CBD EssenceTM that will instill customer trust and loyalty well into the future. CBD EssenceTM is only the first in many planned offerings of CBD-infused pharmaceuticals and nutraceutical under our umbrella.”

Tetrahydrocannabinol (THC), the psychoactive phytocannabinoid (planet-based) found in cannabis, has rapidly become eclipsed by the non-psychoactive phytocannabinoid, Cannabidiol (CBD), and derived mainly from Hemp, which is considered to have wider-ranging medical applications. CBD has even received orphan drug status in the U.S., fast-tracking the substance for use in treating a severe, rare form of crippling epilepsy known as Dravet Syndrome. A highly purified CBD extract developed by UK-based GW Pharmaceuticals, has now gone into landmark clinical trialing for epilepsy at the biggest children’s hospital in the country with initial trials that began in April of 2014 which has already shown encouraging results in kids with treatment-resistant epilepsy. There is increasing major demand across the board for hemp based CBD oil, due to a compelling combination of study data, mounting empirical evidence, and positive feedback from parents whose children suffer from debilitating seizures.

About FutureWorld Corp

FutureWorld (Other OTCQB: FWDG), a Delaware corporation, is a U.S. Diversified Holding Company formed to capitalize on the burgeoning Cannabis markets globally. FutureWorld, together with its subsidiaries, focuses on the identification, acquisition, development, and commercialization of cannabis related products, such as industrial Hemp. FutureWorld, through its subsidiaries such as HempTech and CB Scientific, provides personal and professional THC and CBD test kits, pure CBD oil solutions, smart sensor technology, communication network, surveillance security, data analysis for smart cultivation and consultation for the industrial hemp and legal medicinal cannabis. Our wireless agricultural smart sensor networks offer precision to the agriculture, irrigation systems, and greenhouses for the global cannabis and hemp industry. FutureWorld and its subsidiaries do not grow, distribute or sell marijuana. To request further information about FutureWorld, please email us at, log onto our website at or visit us at our Facebook page

Forward-Looking Statements

This press release may contain forward-looking statements covered within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our services and products, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact and involve risks and uncertainties. Our expectations regarding future revenues depend upon our ability to develop and supply products and services that we may not produce today and that meet defined specifications. When used in this press release, the words “plan,” “expect,” “believe,” and similar expressions generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties, including, but not limited to, changes in technology and changes in pervasive markets. This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.

Media Contact
FutureWorld Corp 
Investor Relations
(727) 474-1816 ext. 103

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 |
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

AbbVie Inc. (ABBV) to Host Fourth-Quarter and Full-Year 2021 Earnings Conference Call

AbbVie to Host Fourth-Quarter and Full-Year 2021 Earnings Conference Call AbbVie (NYSE:…

Canopy Growth Corporation (CGC) Announces Fall 2023 Investor Conference and Event Participation

Canopy Growth Announces Fall 2023 Investor Conference and Event Participation Canopy Growth…

AbbVie Inc. (ABBV) Announces Reimbursement for VRAYLAR® (cariprazine) for the Treatment of Schizophrenia

AbbVie Announces Reimbursement for VRAYLAR® (cariprazine) for the Treatment of Schizophrenia under…

Neptune Wellness Solutions Inc. (NEPT) Provides Business and Operational Update

Neptune Wellness Solutions Inc. Provides Business and Operational Update Neptune Wellness Solutions…